Validation of the Tunisian versions of Bath Ankylosing Spondylitis Functional Index (BASFI) and Disease Activity Index (BASDAI)
- PMID: 20180357
Validation of the Tunisian versions of Bath Ankylosing Spondylitis Functional Index (BASFI) and Disease Activity Index (BASDAI)
Abstract
Background: The Bath Ankylosing Spondylitis Functional Index (BASFI) and the Bath Ankylosing Spondylitis Disease Activity (BASDAI) are the most commonly used instruments to evaluate respectively functioning and disease activity in ankylosing spondylitis (AS).
Objective: The aim of this study was to translate, adapt and validate these instruments into the Tunisian language.
Methods: The studied population consisted of 68 AS patients (59 males and 9 females). Their mean age was 37.9 years (range: 18-76). The mean disease duration was 13.6 years (range: 1-40). After translation and retranslation the BASFI and BASDAI questionnaires were administrated to the patients and tested for reliability, internal consistency and construct validity.
Results: The reproducibility of the indices BASFI and BASFAI was good, the intraclass correlation coefficient for reliability was 0.96 (CCI:0.93-0.97) for the BASFI and 0.93 (CCI:0.90-0.97) for the BASDAI, and the coefficient of internal consistency (Cronbach's alpha) was 0.91 for BASFI and 0.90 for BASDAI. Concerning construct validity, both questionnaires were significantly correlated to each other, to the disease-specific instruments (BASG-s, BASMI, BASRI, ASQoL) and to all domains of the SF-36.
Conclusion: The Tunisian versions of the BASFI and the BASDAI preserve the metrological properties of the original versions and were easy to use for the assessment of disease status in ankylosing spondylitis.
Similar articles
-
[The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis].Reumatizam. 2009;56(2):63-76. Reumatizam. 2009. PMID: 20429263 Croatian.
-
The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity.Scand J Rheumatol Suppl. 1999;111:10-6. Scand J Rheumatol Suppl. 1999. PMID: 10503554
-
Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.J Rheumatol. 2004 Dec;31(12):2422-8. J Rheumatol. 2004. PMID: 15570645 Clinical Trial.
-
Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S).Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S47-58. doi: 10.1002/acr.20575. Arthritis Care Res (Hoboken). 2011. PMID: 22588768 Review. No abstract available.
-
Patient-assessed health in ankylosing spondylitis: a structured review.Rheumatology (Oxford). 2005 May;44(5):577-86. doi: 10.1093/rheumatology/keh549. Epub 2005 Feb 3. Rheumatology (Oxford). 2005. PMID: 15695297 Review.
Cited by
-
Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East.Clin Rheumatol. 2012 Nov;31(11):1633-9. doi: 10.1007/s10067-012-2058-5. Epub 2012 Aug 19. Clin Rheumatol. 2012. PMID: 22903740
-
Burden of disease, pain catastrophizing, and central sensitization in relation to work-related issues in young spondyloarthritis patients.Reumatologia. 2024;62(1):35-42. doi: 10.5114/reum/185390. Epub 2024 Mar 18. Reumatologia. 2024. PMID: 38558896 Free PMC article.
-
It is time for an organised, scientific approach to the application of patient-reported outcome measures in clinical studies and trials.Clin Rheumatol. 2019 Feb;38(2):611-615. doi: 10.1007/s10067-018-04403-2. Epub 2018 Dec 18. Clin Rheumatol. 2019. PMID: 30564944
-
Discovery of fecal microbial signatures in patients with ankylosing spondylitis.Arch Rheumatol. 2022 Oct 21;38(2):217-229. doi: 10.46497/ArchRheumatol.2023.9124. eCollection 2023 Jun. Arch Rheumatol. 2022. PMID: 37680522 Free PMC article.
-
Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.Rheumatol Int. 2012 Nov;32(11):3613-8. doi: 10.1007/s00296-011-2186-2. Epub 2011 Nov 20. Rheumatol Int. 2012. PMID: 22101612
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials